
A Cochrane meta-analysis examines if there is any cardiovascular disease prevention benefit from postmenopausal hormone therapy. Plus from The Endocrine Society's 97th Annual Expo, the benefits of abaloparatide in treating osteoporosis and the impact of smoking while pregnant on the diabetes risk of female children.














